ATLASReplimune Group (REPL) earnings date: expected February 8–14
Replimune Group (REPL) has not announced its next earnings date yet. Based on its last 3 reports, ATLAS expects it around February 8–14. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on REPL
| Last price | $17.61 (+1.3%) |
|---|---|
| Normal 1-day range (±1σ) | ±6.1% |
| Earnings beat history | Beat the EPS estimate in 4 of the last 6 reports |
These figures come from the same calibrated model and valuation as the Replimune Group stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around February 8–14 (estimate). One email the day before, with ATLAS’s read on Replimune Group. You can switch it off at any time.
Alert me before REPL reportsFree to start. Creating an account takes under a minute.
REPL earnings at a glance
| Next report | Not announced · expected around February 8–14 (ATLAS estimate) |
|---|---|
| Last report | Oct 28, 2026 · Beat |
| Beat rate (last 6 reports) | 4 of 6 (67%) |
| Average EPS surprise | +7.1% |
| Average move around a report | ±3.4% (last 5) |
| Sector | Healthcare · Biotechnology |
The expected window is an ATLAS estimate: it takes the typical gap between Replimune Group’s last 3 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
Replimune Group earnings history: last 6 reports
Replimune Group last reported on Oct 28, 2026: EPS of -$0.54 against an estimate of -$0.70 (+22.9% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 28, 2026 | -$0.70 | -$0.54 | +22.9% | Beat | – |
| Aug 14, 2026 | -$0.77 | -$0.72 | +6.5% | Beat | -3.7% |
| Jun 29, 2026 | -$0.72 | -$0.76 | -5.6% | Miss | -4.8% |
| Mar 31, 2026 | $0.59 | $0.66 | +11.9% | Beat | +5.7% |
| Feb 11, 2026 | $2.08 | $2.10 | +1.0% | In line | +2.3% |
| Feb 3, 2026 | -$0.82 | -$0.77 | +6.1% | Beat | +0.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for REPL
See the fair value, the probability range and the earnings history of Replimune Group on its ATLAS page.
Replimune Group (REPL) stock analysisPlans from €3.99 a month.
Replimune Group earnings: frequently asked questions
When is Replimune Group (REPL) next earnings date?
Replimune Group has not announced its next report. Its last 3 reports came Oct 28, 2026, Aug 14, 2026, Mar 31, 2026, so ATLAS estimates the next one around February 8–14. This is an estimate based on that pattern, not a confirmed date.
How often does REPL beat earnings estimates?
Of its last 6 reports with a recorded result, Replimune Group beat the EPS estimate 4 times; the average surprise was +7.1%. Past results do not predict the next one.
How much does REPL move around earnings?
Over its last 5 reports the stock moved an average of 3.4% (absolute, from the close before the report day to the close after it), and finished higher 3 of 5 times.
Did Replimune Group beat earnings estimates last quarter?
Replimune Group last reported on Oct 28, 2026: EPS of -$0.54 against an estimate of -$0.70 (+22.9% surprise), a beat.
How much does REPL usually move in a day?
On a normal trading day the ATLAS model puts REPL’s one-day range at about ±6.1%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer